I

International Journal of Pharmaceutical Compounding

About

Bio

Written by professionals for pharmacists in response to the burgeoning healthcare trend to individualize patient needs. Editorial covers topics relevant and necessary to empower pharmacists to meet the needs for today's patients. Includes case studies as well as reports on specific practices and techniques, ethical issues and regulatory issues.

Email

email@cision.one

Website

site@cision.one

Social media

linkedin x facebook reddit

Location

United States of America

Frequency

upgrade

Circulation

upgrade

Sectors

Health & Medicine, Healthcare, Pharmaceuticals, Pharmacies, Science


Is this you? We'd love to hear from you, contact our journalist team.
Contact us to unlock the full profile

Most recent articles by International Journal of Pharmaceutical Compounding

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet
Contact us to explore recent articles

Explore outlets similar to International Journal of Pharmaceutical Compounding

  • The New York Times
    The New York Times

    The New York Times offers the latest news from around the world. It has several different editions for Eastern and national regions. In addition, the paper gets much of its content and reporting from its many bureaus. The foreign desk oversees correspondents and stringers around the world. Daily deadlines are usually between 5pm and 6pm ET. The paper does not accept artwork. The lead time for news coverage is one day to one week, the lead time for special section features is three weeks. The lead time for advertising is 30 days.

    View
  • The Sun
    The Sun

    The Sun was launched in 1969 with the slogan “forward with the people,” because that is what we believe in. The Sun cares about quality of life, the kind of world we live in, and about people. The Sun is more than a newspaper. It is an instigator, an entertainer, a cultural reference point, a finger on the pulse and a daily relationship. The Sun has been a campaigning newspaper since its inception and continues to be so today, with recent reporting focusing on the plight of refuge shelters for abused women and on male suicide. The Sun strives to the very highest standards of accuracy in its reporting and continues to invest in original journalism in print and online.

    View
  • CNN
    CNN

    CNN is a worldwide news and information network providing live, continuous coverage of news from around the globe, 24 hours a day. Regular programs on the network spotlight public affairs, news, military activity, government, politics, science, technology, business, finance, food, health, medicine, fashion, sports, arts and entertainment. CNN emphasizes topical and in-depth interviews and discussions with newsmakers, politicians, celebrities and people in the news. CNN is viewed predominantly by adults interested in daily national and international news.

    View
  • Axios
    Axios

    Launched in 2017, Axios covers media trends, tech, business, science and politics.

    View
  • The Philadelphia Inquirer
    The Philadelphia Inquirer

    Philadelphia Inquirer is a broadsheet newspaper written for residents in the Philadelphia area. It covers local, national and international news, as well as local zoned coverage of the suburbs and surrounding regions, business, technology, features, entertainment and sports.

    View
Use CisionOne to find more relevant outlets

Contact International Journal of Pharmaceutical Compounding and get access to over 850K accurate, up-to-date media profiles.

Discover the stories that impact your brand. In realtime.

CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.